Literature DB >> 17404613

HOX deregulation in acute myeloid leukemia.

Kim L Rice1, Jonathan D Licht.   

Abstract

The deregulation of homeobox (HOX) genes in acute myeloid leukemia (AML) and the potential for these master regulators to perturb normal hematopoiesis is well established. To date, overexpression of HOX genes in AML has been attributed to specific chromosomal aberrations and abnormalities involving mixed-lineage leukemia (MLL), an upstream regulator of HOX genes. The finding reported in this issue of the JCI by Scholl et al. that caudal-type homeobox transcription factor 2 (CDX2), which is capable of affecting HOX gene expression during embryogenesis, is overexpressed in 90% of patients with AML and induces a transplantable AML in murine models provides an alternative mechanism for HOX-induced leukemogenesis and yields important insights into the hierarchy of HOX gene regulation in AML (see the related article beginning on page 1037).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404613      PMCID: PMC1838955          DOI: 10.1172/JCI31861

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

Review 1.  Hox, ParaHox, ProtoHox: facts and guesses.

Authors:  J Garcia-Fernàndez
Journal:  Heredity (Edinb)       Date:  2005-02       Impact factor: 3.821

Review 2.  The molecular pathology of acute myeloid leukemia.

Authors:  Jonathan D Licht; David W Sternberg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

3.  Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.

Authors:  B F Goemans; C M Zwaan; M Miller; M Zimmermann; A Harlow; S Meshinchi; A H Loonen; K Hählen; D Reinhardt; U Creutzig; G J L Kaspers; M C Heinrich
Journal:  Leukemia       Date:  2005-09       Impact factor: 11.528

4.  Upregulated hoxC4 induces CD14 expression during the differentiation of acute promyelocytic leukemia cells.

Authors:  Dong-Yeon Kim; So-Jung Choi; Sun-Hee Kim; Hee-Yong Chung; Seok Yi; Dong-Wook Kim; Chun-Chu Kim; Tae-Hee Han
Journal:  Leuk Lymphoma       Date:  2005-07

5.  Homeobox gene expression in the intestinal epithelium of adult mice.

Authors:  R James; J Kazenwadel
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

6.  Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics.

Authors:  J Roche; C Zeng; A Barón; S Gadgil; R M Gemmill; I Tigaud; X Thomas; H A Drabkin
Journal:  Leukemia       Date:  2004-06       Impact factor: 11.528

7.  High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets.

Authors:  Carsten Müller-Tidow; Joachim Schwäble; Björn Steffen; Nicola Tidow; Burkhardt Brandt; Kerstin Becker; Eric Schulze-Bahr; Hartmut Halfter; Ulf Vogt; Ralf Metzger; Paul M Schneider; Thomas Büchner; Christian Brandts; Wolfgang E Berdel; Hubert Serve
Journal:  Clin Cancer Res       Date:  2004-02-15       Impact factor: 12.531

8.  Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos.

Authors:  J Partanen; L Schwartz; J Rossant
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

9.  Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13;q12).

Authors:  A Chase; A Reiter; L Burci; G Cazzaniga; A Biondi; J Pickard; I A Roberts; J M Goldman; N C Cross
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

10.  Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia.

Authors:  T Nakamura; D A Largaespada; M P Lee; L A Johnson; K Ohyashiki; K Toyama; S J Chen; C L Willman; I M Chen; A P Feinberg; N A Jenkins; N G Copeland; J D Shaughnessy
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

View more
  36 in total

Review 1.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

2.  Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.

Authors:  Jolanta Grembecka; Shihan He; Aibin Shi; Trupta Purohit; Andrew G Muntean; Roderick J Sorenson; Hollis D Showalter; Marcelo J Murai; Amalia M Belcher; Thomas Hartley; Jay L Hess; Tomasz Cierpicki
Journal:  Nat Chem Biol       Date:  2012-01-29       Impact factor: 15.040

3.  Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice.

Authors:  Amy Brock; Silva Krause; Hu Li; Marek Kowalski; Michael S Goldberg; James J Collins; Donald E Ingber
Journal:  Sci Transl Med       Date:  2014-01-01       Impact factor: 17.956

Review 4.  Challenges and opportunities in targeting the menin-MLL interaction.

Authors:  Tomasz Cierpicki; Jolanta Grembecka
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

5.  Glycogen synthase kinase-3 and leukemia: restoring the balance.

Authors:  Noah W Birch; Nancy J Zeleznik-Le
Journal:  Cancer Cell       Date:  2010-06-15       Impact factor: 31.743

Review 6.  Beyond Hox: the role of ParaHox genes in normal and malignant hematopoiesis.

Authors:  Vijay P S Rawat; R Keith Humphries; Christian Buske
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

7.  Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia.

Authors:  Tomasz Cierpicki; Laurie E Risner; Jolanta Grembecka; Stephen M Lukasik; Relja Popovic; Monika Omonkowska; David D Shultis; Nancy J Zeleznik-Le; John H Bushweller
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

8.  A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster.

Authors:  Xueqing Zhang; Zheng Lian; Carolyn Padden; Mark B Gerstein; Joel Rozowsky; Michael Snyder; Thomas R Gingeras; Philipp Kapranov; Sherman M Weissman; Peter E Newburger
Journal:  Blood       Date:  2009-01-14       Impact factor: 22.113

9.  Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.

Authors:  Piu Wong; Masayuki Iwasaki; Tim C P Somervaille; Chi Wai Eric So; Chai Wai Eric So; Michael L Cleary
Journal:  Genes Dev       Date:  2007-10-17       Impact factor: 11.361

Review 10.  CTCF-mediated genome organization and leukemogenesis.

Authors:  Yi Qiu; Suming Huang
Journal:  Leukemia       Date:  2020-06-09       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.